Clinical Trial Update: Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer

View source ↗

Summary

Clinical trial update focused on tyrosine kinase inhibitors for metastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Non Small Cell Lung Cancer | Status: UNKNOWN